BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34250724)

  • 1. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
    Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
    Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis.
    Infantino M; Tampoia M; Fabris M; Alessio MG; Previtali G; Pesce G; Deleonardi G; Porcelli B; Musso M; Grossi V; Benucci M; Manfredi M; Bizzaro N
    Rheumatology (Oxford); 2019 Jul; 58(7):1239-1244. PubMed ID: 30726990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.
    Piette Y; De Sloovere M; Vandendriessche S; Dehoorne J; De Bleecker JL; Van Praet L; Vander Mijnsbrugge AS; De Schepper S; Jacques P; De Keyser F; Smith V; Bonroy C
    Clin Exp Rheumatol; 2020; 38(2):212-219. PubMed ID: 31287411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.
    Tan TC; Wienholt L; Adelstein S
    Int J Rheum Dis; 2016 Oct; 19(10):996-1001. PubMed ID: 26621603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
    Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
    Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
    Infantino M; Manfredi M; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Bizzaro N
    Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study.
    Lecouffe-Desprets M; Hémont C; Néel A; Toquet C; Masseau A; Hamidou M; Josien R; Martin JC
    Autoimmunity; 2018 Mar; 51(2):89-95. PubMed ID: 29463118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
    Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
    J Clin Lab Anal; 2016 Nov; 30(6):859-866. PubMed ID: 27074881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity.
    Loarce-Martos J; Calvo Sanz L; Garrote-Corral S; Ballester González R; Pariente Rodríguez R; Rita CG; García-Soidan A; Bachiller-Corral J; Roy Ariño G
    Rheumatol Int; 2023 Jun; 43(6):1101-1109. PubMed ID: 36763166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
    Zhao L; Su K; Liu T; Sun D; Jiang Z
    Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
    Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N
    Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results.
    To F; Ventín-Rodríguez C; Elkhalifa S; Lilleker JB; Chinoy H
    BMC Rheumatol; 2020; 4():28. PubMed ID: 32699830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
    Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
    Front Immunol; 2019; 10():745. PubMed ID: 31024569
    [No Abstract]   [Full Text] [Related]  

  • 19. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
    So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
    Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.